VRCC To Participate In Clinical Trial Evaluating The Efficacy Of A New Drug To Treat Dogs With Inoperable Grade 2 & 3 Mast Cell Tumours

VRCC is participating in a ‘Clinical Trial’ evaluating the efficacy of a New Drug to treat Dogs with inoperable Grade 2 & 3 Mast Cell Tumours VRCC offers all the most modern treatments for Dogs with Mast Cell Tumours but this ‘Trial’ treatment is now available at VRCC for Dogs where current treatment may not be appropriate or where clients do not or are unable to pursue the conventional route. For full details contact: Beatriz Balana Tapia or Dr Susan North at: VRCC Veterinary Referrals No1 Bramston Way Southfields. Laindon. Essex. SS15 6TP Te: 01268 564664

More from

• Vetsure Named Business of the Year at 2025 SME National Business Awards
• Home of hope for Romania's dogs: The pioneering shelter doing things differently
• Pioneering new locum platform transforming veterinary landscape
• Key Stakeholders unite to advance helmet design for equine veterinary professionals
• Hallmarq hails transformational equine imaging technology